Skip to content

A prospective study on the preventive effect of Qingre Lidan granule on stone recurrence in patients with choledocholithiasis

A prospective study on the preventive effect of Qingre Lidan granule on stone recurrence in patients with choledocholithiasis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044889
Enrollment
Unknown
Registered
2021-03-31
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choledocholithiasis

Interventions

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with choledocholithiasis; 2.The patient was over 18 years old; there was no residual stone in the common bile duct after 3.There are no residual stones in the common bile duct after ERCP; 4.The informed consent form was signed by the patient and his family.

Exclusion criteria

Exclusion criteria: 1.Previous abdominal operations to change the normal anatomical structure of the digestive system, such as stomach, liver, biliary tract and pancreas; 2.Take Qingre Lidan granule allergy, there are contraindications of taking Qingre Lidan granule; 3.Take antiacid drugs such as coleomide (cholestyramine), coratipo (Jiangdanning) and antacid drugs containing aluminum hydroxide and / or montmorillonite (aluminum chloride); 4.Have a history of drinking and taking drugs; 5.Diseases with malignant tumors; 6.Pregnant women, breastfeeding or research period have pregnancy preparation plan; 7.Suffering from severe hepatitis.

Design outcomes

Primary

MeasureTime frame
Stone recurrence rate after ERCP;Stone recurrence time;

Secondary

MeasureTime frame
Biochemical liver function index;

Countries

China

Contacts

Public ContactZhang Guixin

The First Affiliated Hospital of Dalian Medical University

zgx0109@126.com+86 18098875925

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026